Fei Kang
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
Papers in
-
- Radiopharmaceutical Chemistry and Applications 17
- Medical Imaging Techniques and Applications 12
- Optical Imaging and Spectroscopy Techniques 8
- Oncology 30
- Peptidase Inhibition and Analysis 21
- Co-authors
- Jing Wang (47 shared papers)Mingru Zhang (26 shared papers)Weidong Yang (16 shared papers)Lisen Lin (3 shared papers)Rui Tian (2 shared papers)Liangcan He (2 shared papers)Zhantong Wang (5 shared papers)Weijing Yang (5 shared papers)
- Journals
- Journal of Nuclear Medicine (13 papers)European Journal of Nuclear Medicine and Molecular Imaging (11 papers)Molecular Pharmaceutics (7 papers)Molecular Imaging and Biology (4 papers)Biomedical Optics Express (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Fei Kang
93 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 109
- Radiology, Nuclear Medicine and Imaging 457
- Biomedical Engineering 731
- Oncology 406
- Immunology 327
- Biomaterials 199
Countries citing papers authored by Fei Kang
This map shows the geographic impact of Fei Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Kang more than expected).
Fields of papers citing papers by Fei Kang
This network shows the impact of papers produced by Fei Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Kang. The network helps show where Fei Kang may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 245 | |
| 2 | 2019 | 226 | |
| 3 | 2020 | 85 | |
| 4 | 2020 | 82 | |
| 5 | 2020 | 66 | |
| 6 | 2015 | 57 | |
| 7 | 2014 | 53 | |
| 8 | 2021 | 49 | |
| 9 | 2019 | 49 | |
| 10 | 2022 | 47 | |
| 11 | 2020 | 46 | |
| 12 | 2024 | 46 | |
| 13 | 2015 | 42 | |
| 14 | 2015 | 36 | |
| 15 | 2019 | 36 | |
| 16 | 2013 | 36 | |
| 17 | 2020 | 34 | |
| 18 | 2013 | 34 | |
| 19 | 2017 | 34 | |
| 20 | 2019 | 33 |
About Fei Kang
Fei Kang is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Pulmonary and Respiratory Medicine, Biomedical Engineering and Cellular and Molecular Neuroscience, having authored 110 papers that have together received 2.0k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (21 papers), Radiopharmaceutical Chemistry and Applications (17 papers), Medical Imaging Techniques and Applications (12 papers), Nanoplatforms for cancer theranostics (12 papers), Prostate Cancer Diagnosis and Treatment (9 papers), Optical Imaging and Spectroscopy Techniques (8 papers), Prostate Cancer Treatment and Research (7 papers) and Neuropeptides and Animal Physiology (7 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (457 citations), Biomedical Engineering (731 citations), Oncology (406 citations), Immunology (327 citations) and Biomaterials (199 citations). Fei Kang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jing Wang, Mingru Zhang, Weidong Yang, Lisen Lin, Rui Tian, Liangcan He, Zhantong Wang, Weijing Yang, Hongzhang Deng and Ying Ma. Their work appears in journals such as Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, Molecular Pharmaceutics, Molecular Imaging and Biology and Biomedical Optics Express.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.